cshl computational cell biology islet assessment

Post on 24-Feb-2016

68 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

DESCRIPTION

CSHL Computational Cell Biology Islet Assessment. July 2012 Allan J. Ropski University of Illinois at Chicago Department of Surgery. Islets of Langerhans. Islet Potency Index FDA requirement for use as a biological drug Sterility, identity, and purity are established - PowerPoint PPT Presentation

TRANSCRIPT

CSHL Computational Cell Biology

Islet AssessmentJuly 2012

Allan J. RopskiUniversity of Illinois at ChicagoDepartment of Surgery

Islets of Langerhans•Islet Potency Index

▫FDA requirement for use as a biological drug▫Sterility, identity, and purity are established

•Reliably predict transplant outcomes▫Glucose-stimulated insulin secretion; β-cell specific▫In-vivo streptozotocin treated mice; Potency Index▫UIC-MS islet assays▫Phase III human clinical trials*; 52-week follow-up

•Microfluidic optimization▫Ca2+; Mitochondrial Potential; Insulin release▫High-throughput assays

Human Islet Cell Composition• 6 isolations• 32 sampled islets

• Rangesα-cells 28 – 75%β-cells 10 – 65%δ-cells 1 – 22%

Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal MicroscopyJournal of Histochemistry & Cytochemistry; Volume 53(9): 1087–1097, 2005Marcela Brissova, Michael J. Fowler, Wendell E. Nicholson, Anita Chu, Boaz Hirshberg, David M. Harlan, and Alvin C. Powers

N

Glycolysis

ATP

insulin granules

Insulin secretion Glucose

pyruvate

Mitochondria

β-Cell

K+

K+ K+

K+

K+K+

K+

K+

K+

K+

Ca2+

K+

Ca2+Ca2+

Ca2+ Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Zn+

Zn+

Zn+

Zn+Zn+

Zn+

Zn+Zn+

KATP-dependent depolarization

Phase I Phase II

Basal

3 15

Basal

18

1 2

3

4

Phase I Phase II Oscillation

Time (min)

Cal

cium

co

ncen

tratio

n

VDCC dependent calcium influx

Glucose-stimulated insulin release

Basal

Time (min)

Mito

chon

dria

l pot

entia

ls

High glucose

Mitochondrial hypopolarization

A

B

C

N

Glycolysis

ATP

insulin granules

Insulin secretion Glucose

pyruvate

Mitochondria

β-Cell

K+

K+ K+

K+

K+K+

K+

K+

K+

K+

Ca2+

K+

Ca2+Ca2+

Ca2+ Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Zn+

Zn+

Zn+

Zn+Zn+

Zn+

Zn+Zn+

KATP-dependent depolarization

Phase I Phase II

Basal

3 15

Basal

18

1 2

3

4

Phase I Phase II Oscillation

Time (min)

Cal

cium

co

ncen

tratio

n

N

Glycolysis

ATP

insulin granules

Insulin secretion Glucose

pyruvate

Mitochondria

β-Cell

K+

K+ K+

K+

K+K+

K+

K+

K+

K+

Ca2+

K+

Ca2+Ca2+

Ca2+ Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Zn+

Zn+

Zn+

Zn+Zn+

Zn+

Zn+Zn+

KATP-dependent depolarization

N

Glycolysis

ATP

insulin granules

Insulin secretion Glucose

pyruvate

Mitochondria

β-Cell

K+

K+ K+

K+

K+K+

K+

K+

K+

K+

Ca2+

K+

Ca2+Ca2+

Ca2+ Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Ca2+

Zn+

Zn+

Zn+

Zn+Zn+

Zn+

Zn+Zn+

KATP-dependent depolarization

Phase I Phase II

Basal

3 15

Basal

18

1 2

3

4

Phase I Phase II

Basal

3 15

Basal

18

11 22

33

44

Phase I Phase II Oscillation

Time (min)

Cal

cium

co

ncen

tratio

n

Phase I Phase II Oscillation

Time (min)

Cal

cium

co

ncen

tratio

n

VDCC dependent calcium influx

Glucose-stimulated insulin release

Basal

Time (min)

Mito

chon

dria

l pot

entia

ls

High glucose

Mitochondrial hypopolarization

A

B

C

Microfluidic System

top related